Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Stichting Lygature (LYG)
EU Transparency Register
319741341874-49 First registered on 18 Mar 2021
Goals / Remit
Our mission is to deliver breakthrough innovations in medical technology and drug development that address unmet medical needs by providing partnership management.
We drive partnerships from idea to success by:
- Creating a safe space for innovation: We are the independent third party, the neutral enabler
- Driving partnerships forward to deliver medical solutions: We focus all our efforts on the success of the partnership
- Providing specialized support for partnerships: We deliver dedicated communication, financial and legal supportMain EU files targeted
Research & innovation in healthcare & life sciences, with a focus on drug discovery & development and medical technology. In particular our interest is in the HorizonEurope framework program, focusing on the Innovative Health Initiative and EDCTP-3
Address
Head Office
Jaarbeursplein 6
Utrecht 3521 AL
NETHERLANDSEU Office
Jaarbeursplein 6
Utrecht 3521 AL
NETHERLANDSWebsite
-
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
This number excludes our direct involvement and EU funded activities in the research projects in which we are a partner.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
FIGON, the integrative platform for innovative drug research in the Netherlands. https://www.figon.nl/about
HollandBIO, Dutch sector organisation (primarily SME's) for innovation in biotech. https://www.hollandbio.nl/Member organisations
None declared
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
5,029,748€
Major funding types in closed year
Public financing, Other, EU funding
Funding types "other" information
Major contributions in closed year
Type Name Amount Contribution European Commission (IMI, EDCPT, H2020) 1,551,515€ Contribution Dutch Ministry of Health (VWS) 333,280€ Contribution Dutch Ministry of Education (OCW) 55,561€ Contribution Partnership revenues 1,097,617€ Contribution Strategic alliances 1,991,775€ Grant IMI-2, EDCTP, H2020 1,551,515€ Major contributions in current year
Type Name Amount Grant IMI-2, EDCPT, H2020 2,318,182€ Other financial info
For current financial year (2024) the amount is the expected budget and includes uncertainties
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
As Lygature we are involved in various research projects, at the moment in particular projects running within the Innovative Medicines Initiative - 2, the Innovative Health Initiative, and EDCTP-2 and 3
Other activities
None declared
Meetings
Meetings
None declared